PFE LONG EARNINGS 7/28 READ HOW TO FIND A GOOD PRICEThis Earning's Season has proved nothing is every guaranteed. IBM is definitely one example although it appears to be crawling its way back up. The closer you are to a Stock's Earnings Date the bigger the difference in the bid/ask price. I bought the $36 Call using the 8/21/2020 expiration for $2.20 the bid/ask price was 2.20/2.21. You have to be patience and look for the price to turn "red" and then either bid lower and/or wait for the price to go down. I placed the trade this morning.Longby mthompson454
PFE LONG OR BUY TARGET UP TO $46Along with the good news about the PFE vaccine, it has increased the chances of success for this stock, and if it surpasses $ 38.5, it will confirm the "Asymmetrical Triangle" pattern. PFE buy : $38.5 PFE target : $46+-1 PFE stop loss : 10% . Current prices are supported on all 3 averages of 25-50-200. Wish you good deals! Longby VictorStone998
PFizer D1 Global EpidemicPfizer is one of the largest pharmaceutical groups in the world. Its shares showed good growth dynamics during the quarantine period. And this is logical. During the global epidemic, medicines sold very well and the company received good income. After the quarantine restrictions were lifted, the shares sank. But recent events in the US offer new growth prospects. The epidemic in the country came out of control. Compliance with the quarantine regime during mass protests is practically impossible. The number of cases is increasing every day in the country. Pfizer is an American manufacturer and its products are very popular in this country. The current situation creates a need for the company's products. And it will be an incentive for stock growth.Longby fx_space_coach4433
Pfizer D1Pfizer shares have very good prospects for growth. After high volatility during quarantine, stocks made quite a small rollback. But the situation with the corono virus is likely to begin a new cycle. New outbreaks of disease are emerging in the United States and other developing countries. In America, the situation is generally out of control. Riots on the streets provoke an increase in people's contacts with each other. And this situation causes high disease rates. In large cities around the world, according to statistics, an increase in diseases is also noticeable. Because the company Pfizer is a manufacturer of pharmaceuticals, now you can not do without it. Moreover, this is an American manufacturer, and the United States is now the main focus of disease.Longby StrongBull77712
$PFE wedge $PFE - Positive news incoming and stock has been beaten down. Broke out of wedge while i was out. Longby IMF_Trading3
PFIZER DAILY ANALYSISHi friends the daily chart of this market shows with a strong probability of a downward trend in the coming days but we must at the same time be vigilant of reversal of this market towards the opposite direction please subscribe for more informationShortby YL_PRO3
$PFE Rips on Vaccine New, but has Hurdles AbovePFE shares popped higher in response to positive virus news. The stock still has hurdles in front of it, including confluence MA resistance at $36 and critical sloped trendline pattern resistance above that in the $37.50 area.by GregFolin118
FDA Approves BAVENCIO as First-Line Maintenance Treatment for PaPFE: Pfizer Inc. 2020-06-30 19:30:00 FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial CarcinomaLongby RocketTickers5
@PFE - BUY based on CCI 20 Close (-76.91)BUY ONLY FOR THIS ONE... @PFE ESTIMATED EPS USD 0.69 - WILL BE UPDATED ON 28 JUL 2020 LAST EPS USD 0.38 LAST DIVIDEND USD 0.61Longby ss8899168189Updated 7
Outlook PFE / Pfizerdue to some open gaps I see some more potential in Pfizer, especially now after some successful results in their tests for a COVID-19 antidote.by TradingHaui6
Pfizer: Strong Sell Opportunity.PFE continues to underperform on the long-term and under the recent fundamentals the pressure on it is growing. The Bearish Megaphone on 1D (RSI = 33.977, MACD = -1.120, ADX = 56.370) has printed a bearish continuation sequence that extends at least towards the 27.90 Support. ** If you like our free content follow our profile to get more daily ideas. ** Comments and likes are greatly appreciated.Shortby InvestingScope13
@PFE - BUY based on CCI 20 Close (-111.14)Buy Only for this One... @PFE Estimated EPS USD 0.69 Last EPS USD 0.61 Last Dividend USD 0.38Longby ss8899168189Updated 3
@PFE - BUY based on CCI 20 Close (-97.02)Buy Only for this One... @PFE Estimated Earning per Share USD 0.69 Last EPS USD 0.61 Last Dividend USD 0.38Longby ss8899168189Updated 5
pfizeri tnhimk we wait bullish price if you see the type candle thats means we wit uptrend until 33.34by nabil_na224
PFE Analysis Weekly Chart White Spinning Top Possible Morning Doji Star Reversal Symmetrical Triangle (Bearish Under 32.58) Daily Chart Symmetrical Triangle (Wide Swings) Bearish Momentum (Candlesticks Weak) Bullish Divergence RSI Consolidating since 06/11 2 Gap Fills 37.58 & 35.89 4hr Chart Falling Wedge Bullish Momentum Bullish Divergence Compressing as we get closer to Weekly Trend LineLongby itsCblast116
PFE Analysis Weekly Chart White Spinning Top Possible Morning Doji Star Reversal Symmetrical Triangle (Bearish Under 32.58) Daily Chart Symmetrical Triangle (Wide Swings) Bearish Momentum (Candlesticks Weak) Bullish Divergence RSI Consolidating since 06/11 2 Gap Fills 37.58 & 35.89 4hr Chart Falling Wedge Bullish Momentum Bullish Divergence Compressing as we get closer to Weekly Trend Line Longby itsCblast6
LONG // PFE // US STOCKSTrade Safe! Don`t be greedy! Take care and place small trades! If necessary, I will place more long trades at this asset! All new information or recommendations I will post on the comment section of this idea! In my opinion, this stock is at a good opportunity and has good potential for the stock price to go up!Longby davelar7
Triangle: Waiting on BreakoutBreakout: 34 Stop: Below 32.5 Target 1: 40 Target 2: 47 to 51Longby lauralea5
Long position with a high benefit/risk ratioLong position with a high benefit/risk ratio Longby LucianoAscone4